15年PNPLA3:通过人类遗传学改变肝病学
Stefano Romeo1,2,3, Luca Valenti4,5
1Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.
概括
这种PNPLA3 p.I148M遗传变异显著影响了脂肪性肝病 (SLD) 的风险和严重程度. 新兴的PNPLA3抑制剂在治疗肝脏疾病方面显示出精准医学的前景.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 遗传学 是一个遗传学.
- 代谢疾病 代谢疾病
背景情况:
- 脂肪性肝病 (Steatotic liver disease,SLD) 是一种普遍存在的全球性疾病,由肝细胞中的脂质积累驱动,与代谢功能障碍,酒精,毒素和遗传学有关.
- PNPLA3 p.I148M 变体是SLD的主要遗传决定因素,影响疾病易感性,肝硬化进展和肝细胞癌风险的变化.
研究的目的:
- 突出PNPLA3 p.I148M变异在脂肪性肝病的发病和进展中的关键作用.
- 审查对PNPLA3在脂质和视网代谢中的作用的机制性见解.
- 讨论针对PNPLA3的治疗潜力,用于肝病学中的精准医学方法.
主要方法:
- 对识别PNPLA3 p.I148M变异的全基因组关联研究的审查.
- 对阐明PNPLA3机械影响的实验模型的分析.
- 对PNPLA3抑制剂 (siRNA,反感性寡核酸) 的第一阶段临床试验数据的评估.
主要成果:
- 这种PNPLA3 p.I148M变体大大增加了肝硬化症,炎症,纤维化和肝细胞癌的风险.
- 同卵性携带者表现出对肝损伤的高度易感性,变体与肥胖和胰岛素抵抗等环境因素之间的相互作用.
- 在使用PNPLA3抑制剂的同卵性载体中,第一阶段试验显示肝脂肪和炎症显著减少 (高达40%).
结论:
- 发现PNPLA3的作用有助于我们更好地了解SLD和相关疾病.
- 向PNPLA3代表了精准医学在控制脂肪性肝病方面的有希望的策略.
- PNPLA3是SLD的验证治疗标,为新的治疗干预提供了潜在的潜力.
相关概念视频
01:28Human Genetics
727
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
727
01:05Single Nucleotide Polymorphisms-SNPs
15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
82
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
82
02:30Genomic Imprinting and Inheritance
35.3K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.3K
02:59Animal Mitochondrial Genetics
8.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.0K